Gliclazide is a sulfonylurea compound used as an active pharmaceutical ingredient. It acts as a hypoglycemic agent, a radical scavenger, and an insulin secretagogue, making it significant in pharmaceutical manufacturing for metabolic research.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Gliclazide?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(2-pyridinyl)-beta-alanine ethyl ester hydrochloride
pharmaceutical raw material
Dabigatran
pharmaceutical raw material
Dabigatran etexilate
pharmaceutical raw material
Asciminib hydrochloride
pharmaceutical raw material
Gliclazide-d4 (phenyl-d4)
research compound
The international HS code for Gliclazide (CAS 21187-98-4) is 2935.90.
2935.90
2935 90 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
1-(3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-3-(4-methylphenyl)sulfonylurea
BOVGTQGAOIONJV-UHFFFAOYSA-N
CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2
Sourcing Gliclazide?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.